Evidence map›Paper›PMID 35303855›Full record

ArticleBMC public health2022

Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia.

Jack Wallace, Yinzong Xiao, Jess Howell, Alex Thompson, Nicole Allard, Emily Adamson, Jacqui Richmond, Behzad Hajarizadeh, Melanie Eagle, Joseph Doyle and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jack Wallace *Burnet Institute, Melbourne, VIC, 3004, Australia. jack.wallace@burnet.edu.au.ORCID 0000-0002-4738-7316
Yinzong Xiao *Burnet Institute, Melbourne, VIC, 3004, Australia.ORCID 0000-0001-8360-5352
Jess HowellBurnet Institute, Melbourne, VIC, 3004, Australia.ORCID 0000-0002-9269-6249
Alex ThompsonDepartment of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, 3065, Australia.ORCID 0000-0001-9882-0071
Nicole AllardWorld Health Organization Collaborating Centre for Viral Hepatitis, The Doherty Institute, Melbourne, VIC, 3004, Australia.ORCID 0000-0001-7261-3568
Emily AdamsonBurnet Institute, Melbourne, VIC, 3004, Australia.
Jacqui RichmondBurnet Institute, Melbourne, VIC, 3004, Australia.ORCID 0000-0001-7556-786X
Behzad HajarizadehKirby Institute, University of New South Wales Sydney, Kensington, NSW, 2052, Australia.ORCID 0000-0003-2212-2028
Melanie EagleHepatitis Victoria, Brunswick, VIC, 3056, Australia.
Joseph DoyleBurnet Institute, Melbourne, VIC, 3004, Australia.ORCID 0000-0001-7198-0833
Margaret HellardBurnet Institute, Melbourne, VIC, 3004, Australia.ORCID 0000-0002-5055-3266
Burnet Institute · AUAustralian Centre for HIV and Hepatitis Virology Research · AUPeter Doherty Institute · AUThe University of Melbourne · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis B is a chronic viral infection, a leading cause of primary liver cancer and identified as a major public health priority by the World Health Organization. Despite a high proportion of people in Australia who have been diagnosed with hepatitis B, significant gaps remain in health care access and in accurate knowledge about hepatitis B. Most people with hepatitis B in Australia were born in China, where the infection has an intergenerational impact with significant social implications resulting from the infection. Understanding how people of Chinese ethnicity with hepatitis B understand and respond to hepatitis B is imperative for reducing morbidity, mortality, and the personal and social impact of the infection.

methodsQualitative semi-structured interviews with people with hepatitis B of Chinese ethnicity recruited through a specialist service identified the advice people with hepatitis B thought was important enough to inform the experience of people newly diagnosed with hepatitis B. A thematic analysis of the data privileged the lived experience of participants and their personal, rather than clinical, explanations of the virus.

resultsHepatitis B infection had psychological and physical consequences that were informed by cultural norms, and to which people had responded to with significant behavioural change. Despite this cohort being engaged with specialist clinical services with access to the most recent, comprehensive, and expert information, much of the advice people with hepatitis B identified as important for living with hepatitis B was not based on biomedical understandings. Key suggestions from people with hepatitis B were to form sustainable clinical relationships, develop emotional resilience, make dietary changes, regulate energy, and issues related to disclosure.

conclusionsThe study highlights conflicts between biomedical and public health explanations and the lived experience of hepatitis B among people of Chinese ethnicity in Australia. Beliefs about hepatitis B are embedded within cultural understandings of health that can conflict with bio-medical explanations of the infection. Acknowledging these perspectives provides for insightful communication between health services and their clients, and the development of nuanced models of care informed by the experience of people with hepatitis B.

Indexed as

Hepatitis BAsian PeopleAustraliaChinaEthnicityHumansChinaDiagnosisHealth beliefsHealth informationHepatitis B virus

Identifiers

PMID35303855
PMCPMC8932317
OpenAlexW4220971608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.